Why Johnson & Johnson's Strong Pharmaceutical Business Is A Concern By: Benzinga via Benzinga April 14, 2015 at 14:45 PM EDT Johnson & Johnson (NYSE: JNJ) came out with better-than-expected earnings on Tuesday, despite the strong headwind it faced from ... Read More >> Related Stocks: AbbVie Johnson & Johnson